ONCOTHYREON (NASDAQ:ONTY)

4.70

+0.04 (0.86%)

ONCOTHYREON (NASDAQ:ONTY) Delayed :
Previous Close	$4.66	52 Week High	$7.77
Open	$4.66	52 Week Low	$0.65
Day High	$4.70	P/E	12.05
Day Low	$4.56	EPS	$0.39
Volume	113,620
More ONTY Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
IRE	4	KERX	3
TWGP	2	TSPT	2
CTRP	2	AIB	2
PMRY	2	DAC	2
DNDN	2	JADE	2
AAP	2	AGEN	2

View All Entities

Nov 11, 2009 04:09 PM Oncothyreon (ONTY) Reports Worse-Than-Expected Q3 Loss of $0.24
Aug 12, 2009 04:10 PM Oncothyreon Inc. (ONTY) Reports Q2 EPS Results
Mar 9, 2009 04:32 PM Oncothyreon (ONTY) Reports Q4 EPS of $1.06; Comments on Outlook

Nov 11, 2009 05:36 PM After-Hours Movers 11/11: COMS, JMBA, GRRF, CTRP, UBET Higher; GMCR, PDC, BZ, ONTY, BRCD, TTEK Lower
Nov 11, 2009 04:09 PM Oncothyreon (ONTY) Reports Worse-Than-Expected Q3 Loss of $0.24
Nov 10, 2009 03:38 PM Trading Radar for 11/11: Macy's (M), Progressive (PGR), Advanced Auto Parts (AAP), Computer Sciences (CSC) Report
Aug 12, 2009 04:10 PM Oncothyreon Inc. (ONTY) Reports Q2 EPS Results
Aug 3, 2009 12:12 PM Unusual 11 Mid-Day Movers 8/3: PCAP, TSPT, KERX, GGC Higher; HURN, RPRX, SVNT, CSCX Lower

Nov 16, 2009 08:00AM Oncothyreon's PX-866 PI-3 kinase inhibitor named among Top 10 most promising oncology products for partnering by Windhover
Nov 11, 2009 04:01PM Oncothyreon reports third quarter 2009 financial results & provides product pipeline update
Nov 2, 2009 08:02AM Oncothyreon announces webcast of third quarter 2009 financial results conference call
Oct 20, 2009 02:47PM Mentor Capital Cancer Immunotherapy Index Improves at a 320% Annualized Rate for Quarter
Oct 5, 2009 08:00AM Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors

Oct 18, 2009 12:22 PM Oncothyreon and OncoGenex: Room to Rise
Oct 12, 2009 05:41 PM Dendreon: New Board Members Appointed, Things Have Never Looked Brighter
Oct 11, 2009 07:46 AM Stock Watch: BDSI, ACTC.PK, ONTY
Sep 20, 2009 04:50 PM Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Sep 11, 2009 05:49 AM Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up

Huron Ivestigation
on Aug 3, 2009
at 03:40 PM Huron Consulting under investigation Hi All – Thought I’d provide a quick link for any investors reading this piece – I work for a law firm that’s investigating Huron on behalf of investors. You can learn more about the investigation here – www.hbsslaw.com/huron. HBSS is looking into possible issues with over-reported earnings, kickbacks to company insiders, and how and when the company notified shareholders.
Article: Morning Movers 8/3: KERX, TSPT, TSEM, ICAD, AMFI Higher; HURN, RPRX, ADAT, SVNT Lower

No comments are currently available.